Agenus maintains a global footprint by way of collaborations and partnerships with major pharmaceutical and biotechnology providers in North America, Europe and Asia. Its agreements include investigation and improvement collaborations, license arrangements and co-progress packages targeted at accelerating the interpretation of novel immunotherapies